X4 Pharmaceuticals CEO Paula Ragan's 2019 pay jumps 171% to $2.5M
X4 Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: April 28, 2020
X4 Pharmaceuticals reported fiscal year 2019 executive compensation information on April 28, 2020.
In 2019, four executives at X4 Pharmaceuticals received on average a compensation package of $1.4M, a 20% decrease compared to previous year.
Average pay of disclosed executives at X4 Pharmaceuticals
Paula Ragan, Chief Executive Officer, received $2.5M in total, which increased by 171% compared to 2018. 36% of Ragan's compensation, or $893K, was in option awards. Ragan also received $286K in non-equity incentive plan, $492K in salary, $825K in stock awards, as well as $1.2K in other compensation.
Michael Gray, Chief Executive Officer, received a compensation package of $1.1M, which decreased by 61% compared to previous year. 92% of the compensation package, or $1M, was in other compensation.
E. Lynne Kelley, M.D., FACS, Chief Medical Officer, earned $970K in 2019.
Adam S. Mostafa, Chief Financial Officer, received $866K in 2019, which increases by 38% compared to 2018.
Related executives
You may also like
Source: SEC filing on April 28, 2020.